DE10302452B4 - Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung - Google Patents

Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Download PDF

Info

Publication number
DE10302452B4
DE10302452B4 DE10302452A DE10302452A DE10302452B4 DE 10302452 B4 DE10302452 B4 DE 10302452B4 DE 10302452 A DE10302452 A DE 10302452A DE 10302452 A DE10302452 A DE 10302452A DE 10302452 B4 DE10302452 B4 DE 10302452B4
Authority
DE
Germany
Prior art keywords
alkyl
alkenyl
alkynyl
alkylene
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10302452A
Other languages
German (de)
English (en)
Other versions
DE10302452A1 (de
Inventor
Elisabeth Dr. Defossa
Dieter Dr. Kadereit
Thomas Dr. Klabunde
Hans-Joerg Dr. Burger
Andreas Dr. Herling
Karl-Ulrich Dr. Wendt
Erich von Dr. Roedern
Karl Dr. Schoenafinger
Alfons Dr. Enhsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10302452A priority Critical patent/DE10302452B4/de
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Priority to HR20050667A priority patent/HRP20050667A2/xx
Priority to AT04700448T priority patent/ATE443697T1/de
Priority to MXPA05007515A priority patent/MXPA05007515A/es
Priority to KR1020057013500A priority patent/KR20050104351A/ko
Priority to RU2005126606/04A priority patent/RU2005126606A/ru
Priority to AU2004205352A priority patent/AU2004205352A1/en
Priority to CA002513286A priority patent/CA2513286A1/en
Priority to BR0406840-8A priority patent/BRPI0406840A/pt
Priority to JP2006500523A priority patent/JP4557963B2/ja
Priority to PL04376456A priority patent/PL376456A1/xx
Priority to PCT/EP2004/000041 priority patent/WO2004065356A1/de
Priority to EP04700448A priority patent/EP1590322B1/de
Priority to DE502004010108T priority patent/DE502004010108D1/de
Priority to CNA200480002674XA priority patent/CN1798730A/zh
Priority to US10/763,877 priority patent/US7179941B2/en
Publication of DE10302452A1 publication Critical patent/DE10302452A1/de
Application granted granted Critical
Publication of DE10302452B4 publication Critical patent/DE10302452B4/de
Priority to ZA200504647A priority patent/ZA200504647B/en
Priority to CO05071890A priority patent/CO5690542A2/es
Priority to MA28408A priority patent/MA27649A1/fr
Priority to NO20053876A priority patent/NO20053876L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE10302452A 2003-01-23 2003-01-23 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Expired - Fee Related DE10302452B4 (de)

Priority Applications (20)

Application Number Priority Date Filing Date Title
DE10302452A DE10302452B4 (de) 2003-01-23 2003-01-23 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2004/000041 WO2004065356A1 (de) 2003-01-23 2004-01-07 Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
MXPA05007515A MXPA05007515A (es) 2003-01-23 2004-01-07 Metodo para la produccion de derivados de acil-fenil-urea sustituidos por amino-carbonilo y el uso de los mismos.
KR1020057013500A KR20050104351A (ko) 2003-01-23 2004-01-07 카보닐-아미노 치환된 아실 페닐 우레아 유도체, 이의제조방법 및 이의 용도
RU2005126606/04A RU2005126606A (ru) 2003-01-23 2004-01-07 Карбониламино-замещенные производные ацил-фенил-мочевины, способ их получения и их применение
AU2004205352A AU2004205352A1 (en) 2003-01-23 2004-01-07 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
AT04700448T ATE443697T1 (de) 2003-01-23 2004-01-07 Carbonylamino-substituierte acyl-phenyl- harnstoffderivate, verfahren zu deren herstellung und deren verwendung
BR0406840-8A BRPI0406840A (pt) 2003-01-23 2004-01-07 Derivados de acil-fenil-uréia substituìdos por carbonilamino, processos para a sua preparação e sua aplicação
JP2006500523A JP4557963B2 (ja) 2003-01-23 2004-01-07 カルボニル−アミノ置換アシルフェニル尿素誘導体、その製造方法及び使用
PL04376456A PL376456A1 (en) 2003-01-23 2004-01-07 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
HR20050667A HRP20050667A2 (en) 2003-01-23 2004-01-07 Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
CA002513286A CA2513286A1 (en) 2003-01-23 2004-01-07 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
EP04700448A EP1590322B1 (de) 2003-01-23 2004-01-07 Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
CNA200480002674XA CN1798730A (zh) 2003-01-23 2004-01-07 碳酰氨基取代的酰基苯基脲衍生物、其制备方法和用途
DE502004010108T DE502004010108D1 (de) 2003-01-23 2004-01-07 Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
US10/763,877 US7179941B2 (en) 2003-01-23 2004-01-23 Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
ZA200504647A ZA200504647B (en) 2003-01-23 2005-06-07 Carbonyl-amino substituted acyl phenyl urea derivatives method for the production and use thereof
CO05071890A CO5690542A2 (es) 2003-01-23 2005-07-21 Metodo para la produccion de derivados de acil-fenil-urea sustituidos por animo-carbonilo y el uso de los mismos
MA28408A MA27649A1 (fr) 2003-01-23 2005-07-22 Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.
NO20053876A NO20053876L (no) 2003-01-23 2005-08-18 Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10302452A DE10302452B4 (de) 2003-01-23 2003-01-23 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung

Publications (2)

Publication Number Publication Date
DE10302452A1 DE10302452A1 (de) 2004-08-12
DE10302452B4 true DE10302452B4 (de) 2005-02-24

Family

ID=32694928

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10302452A Expired - Fee Related DE10302452B4 (de) 2003-01-23 2003-01-23 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
DE502004010108T Expired - Lifetime DE502004010108D1 (de) 2003-01-23 2004-01-07 Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE502004010108T Expired - Lifetime DE502004010108D1 (de) 2003-01-23 2004-01-07 Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung

Country Status (18)

Country Link
EP (1) EP1590322B1 (https=)
JP (1) JP4557963B2 (https=)
KR (1) KR20050104351A (https=)
CN (1) CN1798730A (https=)
AT (1) ATE443697T1 (https=)
AU (1) AU2004205352A1 (https=)
BR (1) BRPI0406840A (https=)
CA (1) CA2513286A1 (https=)
CO (1) CO5690542A2 (https=)
DE (2) DE10302452B4 (https=)
HR (1) HRP20050667A2 (https=)
MA (1) MA27649A1 (https=)
MX (1) MXPA05007515A (https=)
NO (1) NO20053876L (https=)
PL (1) PL376456A1 (https=)
RU (1) RU2005126606A (https=)
WO (1) WO2004065356A1 (https=)
ZA (1) ZA200504647B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5385605B2 (ja) * 2005-03-11 2014-01-08 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｐ結合カセットトランスポーターのモジュレーター
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
WO2009081892A1 (ja) * 2007-12-25 2009-07-02 Kissei Pharmaceutical Co., Ltd. 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
EP2543660A4 (en) 2010-03-04 2014-04-30 Ajinomoto Kk PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST DIABETES OR ADIPOSITAS
GB201223308D0 (en) 2012-12-21 2013-02-06 Univ Sunderland Enzyme inhibitors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046236A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
WO2000007991A1 (en) * 1998-08-04 2000-02-17 Astrazeneca Ab Amide derivatives useful as inhibitors of the production of cytokines
WO2001094300A1 (de) * 2000-06-09 2001-12-13 Aventis Pharma Deutschland Gmbh Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2002096864A1 (de) * 2001-05-25 2002-12-05 Aventis Pharma Deutschland Gmbh Carbonsäureamid substituierte phenylharnstoffderivate, verfahren zu ihrer herstellung als arzneimittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508019A (de) * 1968-12-12 1971-05-31 Ciba Geigy Ag Verfahren zur Herstellung neuer Azofarbstoffpigmente
EP0116729B1 (en) * 1983-01-24 1988-10-12 Duphar International Research B.V Benzoylurea compounds and pesticidal compositions comprisingsame
AU601145B2 (en) * 1985-03-01 1990-09-06 Duphar International Research B.V. Benzoyl urea derivatives having anti-tumor activity
EP0324521A3 (en) * 1988-01-11 1991-11-27 Duphar International Research B.V Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
DE10225635C1 (de) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046236A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
WO2000007991A1 (en) * 1998-08-04 2000-02-17 Astrazeneca Ab Amide derivatives useful as inhibitors of the production of cytokines
WO2001094300A1 (de) * 2000-06-09 2001-12-13 Aventis Pharma Deutschland Gmbh Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2002096864A1 (de) * 2001-05-25 2002-12-05 Aventis Pharma Deutschland Gmbh Carbonsäureamid substituierte phenylharnstoffderivate, verfahren zu ihrer herstellung als arzneimittel

Also Published As

Publication number Publication date
DE10302452A1 (de) 2004-08-12
WO2004065356A1 (de) 2004-08-05
MXPA05007515A (es) 2006-01-27
JP4557963B2 (ja) 2010-10-06
MA27649A1 (fr) 2005-12-01
CN1798730A (zh) 2006-07-05
NO20053876D0 (no) 2005-08-18
EP1590322A1 (de) 2005-11-02
ZA200504647B (en) 2006-04-26
ATE443697T1 (de) 2009-10-15
CA2513286A1 (en) 2004-08-05
RU2005126606A (ru) 2006-01-20
BRPI0406840A (pt) 2005-12-13
PL376456A1 (en) 2005-12-27
JP2006516971A (ja) 2006-07-13
AU2004205352A1 (en) 2004-08-05
EP1590322B1 (de) 2009-09-23
DE502004010108D1 (de) 2009-11-05
KR20050104351A (ko) 2005-11-02
NO20053876L (no) 2005-10-12
CO5690542A2 (es) 2006-10-31
HRP20050667A2 (en) 2006-09-30

Similar Documents

Publication Publication Date Title
EP1497262B1 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
EP1651649B1 (de) Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE102005012873B4 (de) Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10333935A1 (de) Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102005017605B4 (de) Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1713803A1 (de) 7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE102005012874A1 (de) Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10225635C1 (de) N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
DE102004004972B3 (de) Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2004007437A9 (de) Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE10215908B4 (de) Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
DE102004004971B3 (de) Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel
DE10302452B4 (de) Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
EP1597247B1 (de) Substituierte 3-(benzoylureido)-thiophenderivate, verfahren zu deren herstellung und deren verwendung
DE10309929B4 (de) Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
US20050014822A1 (en) Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10335092B3 (de) Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
DE102004004973A1 (de) 7-Phenylamino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102005012875A1 (de) Verwendung von Amino substituierten 8-N-Benzimidazolen
DE10306503A1 (de) Substituierte Benzoylureidophenyl-piperidin- und pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
DE102004033405A1 (de) 7-Phenylamino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20130801